The Model-Informed Drug Development Summit is the first and only industry-focused, 3-day strategic meeting on how MIDD is reshaping decision-making and accelerating success in drug development. With the release of the draft ICH M15 guidelines and the FDA’s move to phase out animal testing, now is the time to embed MIDD into your strategy to accelerate regulatory approvals, cut costs, and boost clinical success.

Join senior leaders in pharmacometrics, clinical pharmacology, PK/PD, and modeling to explore and understand how to implement MIDD to help select better candidates sooner, skip phases of clinical development, personalize trials, and shape standout regulatory submissions. With real-world success stories, exclusive insights on M15, and case studies spanning a range of therapeutic areas, this summit is your one-stop shop to unlock the true potential of MIDD. Don’t miss this chance to stay ahead in a rapidly evolving landscape and drive smarter, faster, and more cost-effective drug development.